HOMESTEAD, FL / ACCESS Newswire / March 30, 2026 / Alfred Farrington II, Managing Director of Farrington Capital Group, and Stuart Fine, CEO of Remergify, today announced a transformative "OZ 2.0" inf ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A clinical “hub-and-spoke” model expanded allergy ...